Finance
Finance
HomeZ1TS34 • BVMF
Zoetis Inc Bdr
R$50.00
Sep 12, 10:24:41 PM GMT-3 · BRL · BVMF · Disclaimer
StockBR listed securityUS headquartered
Previous close
R$50.00
Day range
R$49.24 - R$50.05
Year range
R$49.24 - R$69.56
Market cap
65.68B USD
Avg Volume
148.00
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
(USD)Jun 2025Y/Y change
Revenue
2.46B4.19%
Operating expense
822.00M4.45%
Net income
718.00M15.06%
Net profit margin
29.1910.44%
Earnings per share
1.7612.82%
EBITDA
1.11B7.65%
Effective tax rate
20.40%
Total assets
Total liabilities
(USD)Jun 2025Y/Y change
Cash and short-term investments
1.45B-7.62%
Total assets
14.48B2.22%
Total liabilities
9.50B3.23%
Total equity
4.98B
Shares outstanding
443.18M
Price to book
4.46
Return on assets
17.30%
Return on capital
21.29%
Net change in cash
(USD)Jun 2025Y/Y change
Net income
718.00M15.06%
Cash from operations
486.00M-3.19%
Cash from investing
-247.00M-87.12%
Cash from financing
-564.00M26.08%
Net change in cash
-286.00M28.68%
Free cash flow
198.00M-6.33%
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Website
Employees
13,800
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu